blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3052091

EP3052091 - SUSTAINED RELEASE FORMULATIONS CONTAINING METHYLGLYOXAL AND THEIR THERAPEUTIC APPLICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.02.2020
Database last updated on 03.09.2024
FormerThe patent has been granted
Status updated on  22.03.2019
FormerGrant of patent is intended
Status updated on  14.03.2019
FormerExamination is in progress
Status updated on  22.02.2019
FormerGrant of patent is intended
Status updated on  09.10.2018
FormerExamination is in progress
Status updated on  22.12.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Lifecare Innovations Pvt. Ltd.
Udayan, "B", Flat G-4
25/2B/1B Jheel Road
Dhakuria, Near Milan Park
Kolkata 700031 / IN
[2017/07]
Former [2016/32]For all designated states
Manju, Ray
Of 13 Regent Estate
Kolkata 700092 / IN
For all designated states
Jitendra Nath Verma
Of K-52 Ridgewood Estate
DLF Phase IV
Gurgaon 122002 / IN
For all designated states
Lily Verma
Of K-52 Ridgewood Estate
DLF Phase IV
Gurgaon 122002 / IN
Inventor(s)01 / MANJU, Ray
13 Regent Estate
Kolkata 700092 / IN
02 / JINTEDRA, Nath Verma
K-52 Ridgewood Estate
DLF Phase IV
Gurgaon 122002 / IN
03 / LILY, Verma
K-52 Ridgewood Estate
DLF Phase IV
Gurgaon 122002 / IN
 [2019/17]
Former [2016/32]01 / see applicant
...
Representative(s)Zimmermann, Tankred Klaus, et al
Schoppe, Zimmermann, Stöckeler
Zinkler, Schenk & Partner mbB
Patentanwälte
Radlkoferstrasse 2
81373 München / DE
[2016/32]
Application number, filing date13792770.301.10.2013
[2016/32]
WO2013IN00598
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015049689
Date:09.04.2015
Language:EN
[2015/14]
Type: A1 Application with search report 
No.:EP3052091
Date:10.08.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 09.04.2015 takes the place of the publication of the European patent application.
[2016/32]
Type: B1 Patent specification 
No.:EP3052091
Date:24.04.2019
Language:EN
[2019/17]
Search report(s)International search report - published on:EP09.04.2015
ClassificationIPC:A61K9/51, A61K31/121, A61P35/00, A61P31/10, A61P37/02
[2018/42]
CPC:
A61K9/5161 (EP,US); A61K31/12 (US); A61K31/121 (EP,US);
A61K31/198 (US); A61K31/375 (US); A61K31/4045 (US);
A61K47/61 (EP,US); A61K47/6939 (EP,US); A61K9/4816 (US);
A61P31/10 (EP); A61P35/00 (EP); A61P37/02 (EP) (-)
Former IPC [2016/32]A61K9/51, A61K47/48, A61K31/121, A61P35/00, A61P31/10, A61P37/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/32]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERZÖGERT FREIGESETZTE FORMULIERUNGEN MIT METHYLGLYOXAL UND DEREN THERAPEUTISCHEN ANWENDUNGEN[2016/32]
English:SUSTAINED RELEASE FORMULATIONS CONTAINING METHYLGLYOXAL AND THEIR THERAPEUTIC APPLICATIONS[2016/32]
French:FORMULATIONS À LIBÉRATION PROLONGÉE CONTENANT DU MÉTHYLGLYOXAL ET LEUR APPLICATIONS THÉRAPEUTIQUES[2016/32]
Entry into regional phase31.03.2016National basic fee paid 
31.03.2016Designation fee(s) paid 
31.03.2016Examination fee paid 
Examination procedure31.03.2016Examination requested  [2016/32]
21.11.2016Amendment by applicant (claims and/or description)
05.01.2017Despatch of communication of loss of particular rights: Claims {1}
03.01.2018Despatch of a communication from the examining division (Time limit: M06)
11.07.2018Reply to a communication from the examining division
10.10.2018Communication of intention to grant the patent
14.02.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
14.02.2019Fee for grant paid
14.02.2019Fee for publishing/printing paid
13.03.2019Information about intention to grant a patent
13.03.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.01.2018
Opposition(s)27.01.2020No opposition filed within time limit [2020/14]
Fees paidRenewal fee
31.03.2016Renewal fee patent year 03
31.10.2016Renewal fee patent year 04
26.09.2017Renewal fee patent year 05
17.01.2019Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.10.201806   M06   Fee paid on   17.01.2019
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.10.2013
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MK24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
IE01.10.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
[2022/31]
Former [2021/34]HU01.10.2013
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
IE01.10.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
Former [2021/32]HU01.10.2013
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
IE01.10.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
Former [2021/26]AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
IE01.10.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
Former [2020/46]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
IE01.10.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
Former [2020/38]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
LU01.10.2019
BE31.10.2019
CH31.10.2019
LI31.10.2019
Former [2020/35]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
LU01.10.2019
CH31.10.2019
LI31.10.2019
Former [2020/34]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
CH31.10.2019
LI31.10.2019
Former [2020/29]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/26]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/17]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/14]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/11]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/10]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/09]AL24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/04]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2019/52]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/51]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/50]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/49]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/48]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/47]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
NO24.07.2019
Former [2019/44]NL24.04.2019
Cited inInternational search[A]US2011118327  (RAY MANJU [IN]) [A] 1-18 * paragraphs [0082] - [0085]; claims 1-6; tables 10,11 *;
 [XA]  - Manas P. Gupte, "Preparation and Characterization of Methylglyoxal Nanoparticulate Drug Delivery System", Omaha, NE, (20120914), pages 1 - 99, Thesis Creighton University, URL: https://dspace.creighton.edu/xmlui/bitstream/handle/10504/23037/M_Gupte-thesis.pdf?sequence=1, (20140519), XP002724633 [X] 18 * pages 12-13, paragraph 1.2.8 * * page 33, paragraph 3.1 - page 36, paragraph 3.3.2 * * page 41; table 3.1 * * pages 54-56, paragraph 4.1 * * page 63, paragraph 4.4.1.2 * * page 65, paragraph 4.4.1.3 * * page 72, paragraph 4.4.1.6 * * page 81, paragraph 4.6 * * pages 84-85, paragraph 5.2 * [A] 1-17
 [L]  - Anonymous, "Preparation and Characterization of Methylglyoxal Nanoparticulate Drug Delivery System. DSpace/Manakin Repository", pages 1 - 6, Creighton University, URL: https://dspace.creighton.edu/xmlui/handle/10504/23037?show=full, (20140519), XP002724634 [L] 1-18 * page 1 * * To establish publication date of thesis "Preparation and Characterization of Methylglyoxal Nanoparticulate Drug Delivery System" by Manas P. Gupte; page 4 *
 [T]  - ADRITA CHAKRABARTI ET AL, "Immunomodulation of macrophages by methylglyoxal conjugated with chitosan nanoparticles against Sarcoma-180 tumor in mice", CELLULAR IMMUNOLOGY, (20131208), vol. 287, no. 1, doi:10.1016/j.cellimm.2013.11.006, ISSN 0008-8749, pages 27 - 35, XP055118681 [T] 1-18 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.cellimm.2013.11.006
by applicantUS6613793
 US6649192
 US2006073210
 US2006147539
 US2007116772
 US2007116771
 US7265090
 US7291598
 US7309500
 US7381716
 US2008254078
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.